Profile
Hagit Marchaim worked as Senior Vice President-Regulatory Affairs at Alcobra Ltd.
Prior to that, she was Vice President-Regulatory Affairs at CureTech Ltd.
from 2011 to 2013.
From 2009 to 2011, she was Head-Affairs Department at Omrix Biopharmaceuticals Ltd.
Marchaim received her undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.
She also holds an MBA from The College of Management Academic Studies.
Former positions of Hagit Marchaim
| Companies | Position | End |
|---|---|---|
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Corporate Officer/Principal | 01/01/2013 |
Omrix Biopharmaceuticals Ltd.
 Omrix Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Omrix Biopharmaceuticals Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The company is based in Tel Aviv, Israel. | Corporate Officer/Principal | 01/01/2011 |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | General Counsel | - |
Training of Hagit Marchaim
| The Hebrew University of Jerusalem | Doctorate Degree |
| The College of Management Academic Studies | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
CureTech Ltd.
CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Health Technology |
Omrix Biopharmaceuticals Ltd.
Omrix Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Omrix Biopharmaceuticals Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The company is based in Tel Aviv, Israel. | Health Technology |
- Stock Market
- Insiders
- Hagit Marchaim
